UnitedHealth Group (NYSE: UNH) has endured a brutal 2025, with shares down approximately 35% year-to- date. This marks the company's worst annual performance since 2008, when it lost more than 54% during the financial crisis. The stock reached a 52-week low around $235 in August before rebounding roughly 46$328. Despite this sharp decline — or precisely because of it — the depressed valuation has created an attractive entry point for investors. Trading at a forward P/E ratio 18 ...